Australia Markets closed

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
314.46+2.30 (+0.74%)
As of 10:04AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.46
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3325.19
52-week low 3233.01
50-day moving average 3300.93
200-day moving average 3295.78

Share statistics

Avg vol (3-month) 31.28M
Avg vol (10-day) 31.21M
Shares outstanding 5256.69M
Implied shares outstanding 6N/A
Float 8256.01M
% held by insiders 10.26%
% held by institutions 197.14%
Shares short (12 Jan 2023) 42.63M
Short ratio (12 Jan 2023) 42
Short % of float (12 Jan 2023) 41.03%
Short % of shares outstanding (12 Jan 2023) 41.03%
Shares short (prior month 14 Dec 2022) 43.09M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 323 Aug 2000

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin 37.20%
Operating margin (ttm)49.46%

Management effectiveness

Return on assets (ttm)17.48%
Return on equity (ttm)27.67%

Income statement

Revenue (ttm)8.93B
Revenue per share (ttm)34.87
Quarterly revenue growth (yoy)11.10%
Gross profit (ttm)5.35B
Net income avi to common (ttm)3.32B
Diluted EPS (ttm)10.49
Quarterly earnings growth (yoy)6.30%

Balance sheet

Total cash (mrq)10.78B
Total cash per share (mrq)41.94
Total debt (mrq)471.6M
Total debt/equity (mrq)3.39
Current ratio (mrq)5.22
Book value per share (mrq)34.70

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A